Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2009

01-12-2009 | Case Report

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID

Authors: Neslihan Edeer Karaca, Guzide Aksu, Ferah Genel, Nesrin Gulez, Sema Can, Yesim Aydinok, Serap Aksoylar, Emin Karaca, Imren Altuglu, Necil Kutukculer

Published in: Clinical and Experimental Medicine | Issue 4/2009

Login to get access

Abstract

Severe combined immunodeficiencies (SCID) comprise a spectrum of genetic defects that involve both humoral and cellular immunities. Defects in recombinating activating gene 1 (RAG1), RAG2, Artemis, or LIG4 can disrupt V(D)J recombination. Defective V(D)J recombination of the T and B cell receptors is responsible for TBNK+SCID. Amorphic mutations in RAG1 and RAG2 cause TBNK+SCID, whereas hypomorphic mutations cause an immunodeficency characterized by oligoclonal expansion of TCRγδ T cells, severe CMV infection and autoimmunity. First patient is a typical TBNK+SCID with clinical and immunologic findings while the second is atypical with normal immunoglobulin levels, CD4 lymphopenia, elevated TCRγδ T cells, persistent CMV infection, and autoimmune hemolytic anemia. These cases are presented to emphasize that mutations in RAG1 gene may lead to a diverse spectrum of clinical and immunologic findings while hypomorphic mutations may be related with autoimmunity and refractory CMV infection during infancy.
Literature
1.
go back to reference Fischer A, Landais P, Freidrich W, Morgan G, Gerritsen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J (1990) European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 336:850–854PubMedCrossRef Fischer A, Landais P, Freidrich W, Morgan G, Gerritsen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J (1990) European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 336:850–854PubMedCrossRef
2.
go back to reference Villartay JP, Schwarz K, Villa A (2007) V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J (eds) Primary ımmunodeficiency diseases, 2nd edn. Oxford University Press, New York, pp 153–168 Villartay JP, Schwarz K, Villa A (2007) V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J (eds) Primary ımmunodeficiency diseases, 2nd edn. Oxford University Press, New York, pp 153–168
3.
go back to reference Van der Burg M, Weemaes CM, Preijers F, Brons P, Barendregt BH, van Tol MJ, Hoogerbrugge P, van Dongen JJ (2006) B cell recovery after stem cell transplantation of artemis-deficient SCID requires elimination of autologous bone marrow precursor-B cells. Haematologica 91:1705–1709PubMed Van der Burg M, Weemaes CM, Preijers F, Brons P, Barendregt BH, van Tol MJ, Hoogerbrugge P, van Dongen JJ (2006) B cell recovery after stem cell transplantation of artemis-deficient SCID requires elimination of autologous bone marrow precursor-B cells. Haematologica 91:1705–1709PubMed
4.
go back to reference Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F et al (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177–186PubMedCrossRef Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F et al (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177–186PubMedCrossRef
5.
go back to reference Van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH et al (2006) A new type of radiosensitive T−B−NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 116:137–145PubMedCrossRef Van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH et al (2006) A new type of radiosensitive TBNK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 116:137–145PubMedCrossRef
7.
go back to reference Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR (1996) RAG mutations in human B cell negative SCID. Science 274:97–99PubMedCrossRef Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR (1996) RAG mutations in human B cell negative SCID. Science 274:97–99PubMedCrossRef
8.
go back to reference Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885–896PubMedCrossRef Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885–896PubMedCrossRef
9.
go back to reference Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A (2006) RAG-dependent primary immunodeficiencies. Hum Mutat 27:1174–1184PubMedCrossRef Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A (2006) RAG-dependent primary immunodeficiencies. Hum Mutat 27:1174–1184PubMedCrossRef
10.
go back to reference Matangkasombut P, Pichavant M, Saez DE, Giliani S, Mazzolari E, Finocchi A, Villa A, Sobacchi C, Cortes P, Umetsu DT, Notarangelo LD (2008) Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood 111:271–274PubMedCrossRef Matangkasombut P, Pichavant M, Saez DE, Giliani S, Mazzolari E, Finocchi A, Villa A, Sobacchi C, Cortes P, Umetsu DT, Notarangelo LD (2008) Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood 111:271–274PubMedCrossRef
11.
go back to reference Simkus C, Anand P, Bhattacharyya A, Jones JM (2007) Biochemical and folding defects in a RAG1 variant associated with Omenn syndrome. J Immunol 179:8332–8340PubMed Simkus C, Anand P, Bhattacharyya A, Jones JM (2007) Biochemical and folding defects in a RAG1 variant associated with Omenn syndrome. J Immunol 179:8332–8340PubMed
12.
go back to reference Haq IJ, Steinberg LJ, Hoenig M, van der Burg M, Villa A, Cant AJ et al (2007) GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T−B−SCID in patients with defects in RAG genes. Clin Immunol 124:165–169PubMedCrossRef Haq IJ, Steinberg LJ, Hoenig M, van der Burg M, Villa A, Cant AJ et al (2007) GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than TBSCID in patients with defects in RAG genes. Clin Immunol 124:165–169PubMedCrossRef
13.
go back to reference de Villartay JP, Lim A, Al-Mousa H, Dupont S, Déchanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F (2005) Novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 115:3291–3299PubMedCrossRef de Villartay JP, Lim A, Al-Mousa H, Dupont S, Déchanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F (2005) Novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 115:3291–3299PubMedCrossRef
14.
go back to reference Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, Kumaki S, Ishida Y, Kamachi Y, Yachie A (2006) Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan. Allergol Int 55:115–119PubMedCrossRef Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, Kumaki S, Ishida Y, Kamachi Y, Yachie A (2006) Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan. Allergol Int 55:115–119PubMedCrossRef
15.
go back to reference Wada T, Toma T, Okamoto H, Kasahara Y, Koizumi S, Agematsu K, Kimura H, Shimada A, Hayashi Y, Kato M, Yachie A (2005) Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 106:2099–2101PubMedCrossRef Wada T, Toma T, Okamoto H, Kasahara Y, Koizumi S, Agematsu K, Kimura H, Shimada A, Hayashi Y, Kato M, Yachie A (2005) Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 106:2099–2101PubMedCrossRef
Metadata
Title
Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID
Authors
Neslihan Edeer Karaca
Guzide Aksu
Ferah Genel
Nesrin Gulez
Sema Can
Yesim Aydinok
Serap Aksoylar
Emin Karaca
Imren Altuglu
Necil Kutukculer
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2009
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0053-1

Other articles of this Issue 4/2009

Clinical and Experimental Medicine 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine